Jacobien R. Hilberink

M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism

Isabel Weinhäuser, Diego A. Pereira‐Martins, Luciana Yamamoto Almeida et al. · Science Advances · 2023 · 60 citations · Full text

Medicine, Immunology, Oncology +17

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Se young Han, Krzysztof Mrózek, Jenna Voutsinas et al. · Blood Advances · 2021 · 48 citations · Full text

Life Sciences, Genetics, Hematology +17

The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy

Keli Lima, Diego A. Pereira‐Martins, Lívia Bassani Lins de Miranda et al. · Blood Cancer Journal · 2022 · 29 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐<scp>CBF</scp>it)

Celalettin Üstün, Elizabeth A. Morgan, Erica E. M. Moodie et al. · Cancer Medicine · 2018 · 24 citations · Full text

Medicine, Hematology, Oncology +13

Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients

Jacobien R. Hilberink, Carin Hazenberg, Eva van den Berg et al. · Leukemia Research · 2019 · 19 citations · Full text

Medicine, Geriatric Medicine, Hematology +13